Solbinsiran Clinical Trials (2026): 1 Studies for Severe Hypertriglyceridemia
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 Solbinsiran clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Severe Hypertriglyceridemia) and 60 total planned enrollment. 1 Solbinsiran clinical trial is actively recruiting at 29 U.S. sites across 15 states. Most recent activity: NCT07269210 (Aug 2027).
Where to Participate: All Solbinsiran Trial Sites in the U.S. (29 sites across 15 states)
Every actively recruiting Solbinsirantrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| AZ | Axsendo Clinical Research - Peak Heart & Vascular - Phoenix | Phoenix85014 | NCT07269210 | Map |
| AZ | Synexus Clinical Research US, Inc./Orange Grove Family Practice | Tucson85741 | NCT07269210 | Map |
| CA | National Heart Institute | Beverly Hills90211 | NCT07269210 | Map |
| CA | Ark Clinical Research | Long Beach90815 | NCT07269210 | Map |
| CA | Catalina Research Institute, LLC | Montclair91763 | NCT07269210 | Map |
| CA | Valley Clinical Trials, LLC dba Flourish Research | Northridge91325 | NCT07269210 | Map |
| CT | CMR of Greater New Haven, LLC | Hamden06517 | NCT07269210 | Map |
| FL | Northeast Research Institute - Downtown Office | Jacksonville32204 | NCT07269210 | Map |
| FL | Novera Clinical Research | Miami33135 | NCT07269210 | Map |
| FL | Inpatient Research Clinic | Miami Lakes33014 | NCT07269210 | Map |
| FL | Clinical Site Partners, LLC dba Flourish Research | Winter Park32789 | NCT07269210 | Map |
| IL | Great Lakes Clinical Trials - Ravenswood | Chicago60640 | NCT07269210 | Map |
| IN | Investigators Research Group | Brownsburg46112 | NCT07269210 | Map |
| KY | Saint Elizabeth Healthcare - Saint Elizabeth Covington Hospital | Covington41011 | NCT07269210 | Map |
| MD | Flourish Research - Bowie | Bowie20715 | NCT07269210 | Map |
| MA | University of Massachusetts Chan Medical School | Worcester01655 | NCT07269210 | Map |
| NV | AB Clinical Trials | Las Vegas89119 | NCT07269210 | Map |
| NJ | Clinical Research of Philadelphia | Pennington08534 | NCT07269210 | Map |
| NY | Icahn School of Medicine at Mount Sinai | New York10029 | NCT07269210 | Map |
| NY | Weill Cornell Medical College | New York10021 | NCT07269210 | Map |
| TX | Cardiovascular Specialists of Willowbrook | Houston77070 | NCT07269210 | Map |
| TX | Southern Endocrinology Associates | Mesquite75149 | NCT07269210 | Map |
| TX | American Research Corporation at Texas Liver Institute | San Antonio78215 | NCT07269210 | Map |
| TX | Endeavor Clinical Trials | San Antonio78240 | NCT07269210 | Map |
| VA | Stroobants Cardiovascular Center | Lynchburg24501 | NCT07269210 | Map |
| VA | TPMG (Tidewater Physicians Multispecialty Group) Clinical Research | Newport News23606 | NCT07269210 | Map |
| VA | Carilion Clinic | Roanoke24014 | NCT07269210 | Map |
| WA | Eastside Research Associates | Redmond98052 | NCT07269210 | Map |
| WA | UW Medicine Diabetes Institute | Seattle98109 | NCT07269210 | Map |
Solbinsiran clinical trials at a glance: phase × recruitment status
| Phase | recruiting | Total |
|---|---|---|
| P2 | 1 | 1 |
Recruiting Solbinsiran clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07269210 | SOLARIS-1A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia | P2 | Severe Hypertriglyceridemia | 60 | Dec 2025 |
Solbinsiran pivotal trial highlights (Phase 2/3/4)
Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.
| Acronym | NCT | Phase | Status | Indication | Enrollment | PubMed |
|---|---|---|---|---|---|---|
| SOLARIS-1 | NCT07269210 | P2 | recruiting | Severe Hypertriglyceridemia | 60 | — |
All Solbinsiran trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07269210 | SOLARIS-1 | A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia | P2 | recruiting | 60 | Eli Lilly and Company | Dec 2025 |
Solbinsiran clinical trials: frequently asked questions
- How many Solbinsiran clinical trials are there?
- 1 Solbinsiran clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are Solbinsiran clinical trials recruiting in 2026?
- Yes — 1 Solbinsiran trial is actively recruiting in 2026, with 29 U.S. sites across 15 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is Solbinsiran being studied for?
- Solbinsiran is being studied for Severe Hypertriglyceridemia. The trials are grouped by indication on this page.
- What phase is Solbinsiran in?
- Solbinsiran clinical trials span 1 Phase 2. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors Solbinsiran clinical trials?
- The lead sponsor across the most Solbinsiran trials is Eli Lilly and Company. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Solbinsiranas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: